Dynasty Gene
Qingpu · Founded 2018
About Dynasty Gene
Developer of synthetic biology technology and provider of biotechnology consulting services. The company focuses on technology development, technology consulting, technology transfer, and technical services in the biotechnology field, enabling their clients to make advancement in the field of next-generation DNA sequencing (NGS). The company has its own independent intellectual property rights on their Micropore high-throughput DNA synthesis platform, allowing the company to launch a series of products including: liquid biopsy solutions, NGS library capture kits, etc.
Company Facts
- Founded: 2018
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $15.6M
- Last round: Series Unknown (Dec 2021)
- Website: http://www.dynastygene.com
- Phone: +86 400 017 9077
Industries & Categories
Biotechnology, Consulting, Health Care
Canonical: https://fsome.com/organization/dynasty-gene-133398 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.